Catalyst Biosciences, Inc.
Extract: Update, Proxy Fight Director Nomination from a DFAN14A on 08/03/2022   Download
SEC Document
SEC Filing

Termination of Proxy Contest at Catalyst Biosciences, Inc.

On August 3, 2022, JDS1 withdrew its nominations of Shelly C. Lombard, Matthew Stecker, and Igor Volshteyn for election to the Board of Directors (the “Board”) of Catalyst Biosciences, Inc., a Delaware corporation (the “Company”), at the Company’s 2022 Annual Meeting of Stockholders (the “Annual Meeting”). JDS1 also withdrew its non-binding business proposal for consideration by stockholders at the Annual Meeting requesting that the Board take action to declassify the Board.

In connection with the withdrawal of its nominations and non-binding business proposal, JDS1 and the other members of the JDS1 Group have terminated their solicitation of proxies to elect Ms. Lombard and Messrs. Stecker and Volshteyn to the Board at the Annual Meeting.

JDS1’s withdrawal of its director nominations and non-binding business proposal, and the JDS1 Group’s termination of its solicitation of proxies at the Annual Meeting, is not pursuant to any agreement, arrangement, or understanding with the Company or any other person.